Guardant Health, Guardant360 CDx, AstraZeneca, ETCAMAH, camizestrant, CE marking, European Union, companion diagnostics, liquid biopsy, ESR1 mutations,

PALO ALTO, Calif. — October 8, 2026 Guardant Health, Inc. announced that its Guardant360 CDx liquid biopsy test has...